In Brief: House Commerce Committee
House Commerce Committee: John Cohrssen, former staff chief for Vice President Quayle's Council on Competitiveness, will evaluate FDA's approval process for drugs, biologics and devices and focus on health care reform issues for committee Chairman Rep. Bliley (R-Va.), who stated that hearings on FDA will begin as early as the last week of February. Most recently, Cohrssen was minority staff director for the Senate Labor & Human Resources/Aging Subcommittee. He also worked for Sen. Hatch (R-Utah) on the Labor & Human Resources Committee...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth